Ep157: Efficacy and Safety of Cipaglucosidase Alfa/miglustat Versus Alglucosidase Alfa/placebo in Late-Onset Pompe Disease: PROPEL StudyPriya S. Kishnani,Drago Bratkovic,Barry J. Byrne,Jordi Díaz‐Manera,Pascal Laforêt,Tahseen Mozaffar,Ans van der Ploeg,Mark Roberts,António Toscano,Hai Jiang,Sheela Sitaraman,Mitchell H. Goldman,Jeff Castelli,Benedikt SchoserGenetics in Medicine(2022)引用 1|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要